Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPI-1205 is a highly potent and selective inhibitor of EZH2(IC50 : 0.002 μM, EC50 : 0.032 μM) .
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 85.00 | |
2 mg | In stock | $ 123.00 | |
5 mg | In stock | $ 223.00 | |
10 mg | In stock | $ 328.00 | |
25 mg | In stock | $ 556.00 | |
50 mg | In stock | $ 783.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 473.00 |
Description | CPI-1205 is a highly potent and selective inhibitor of EZH2(IC50 : 0.002 μM, EC50 : 0.032 μM) . |
Targets&IC50 | EZH2:0.002 μM |
In vivo | CPI-1205 is a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2.?This compound demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID. |
Synonyms | Lirametostat |
Molecular Weight | 518.57 |
Formula | C27H33F3N4O3 |
CAS No. | 1621862-70-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/ml(183.19 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPI-1205 1621862-70-1 Chromatin/Epigenetic Histone Methyltransferase CPI1205 Lirametostat CPI 1205 inhibitor inhibit